IDEAYA Biosciences to Participate in Upcoming December 2025 Investor Relations Events
IDEAYA Biosciences (NASDAQ: IDYA) announced management will participate in investor events the week of December 2, 2025.
Management appearances include a fireside chat with CEO Yujiro S. Hata at Citi's 2025 Global Healthcare Conference on Dec 2, 2025 at 9:00 AM ET and a fireside chat with CEO Yujiro S. Hata at the 8th Annual Evercore Healthcare Conference on Dec 3, 2025 at 10:50 AM ET.
A live audio webcast will be available via the IDEAYA Investors/Events webpage or through the conference host where permitted, with webcasts replayable for 30 days after the live event.
IDEAYA Biosciences (NASDAQ: IDYA) ha annunciato che la direzione parteciperà a eventi per gli investitori nella settimana del 2 dicembre 2025.
Le apparizioni della direzione includono una chiacchierata informale con il CEO Yujiro S. Hata alla Citi Global Healthcare Conference 2025 il 2 dicembre 2025 alle ore 9:00 ET e una chiacchierata informale con il CEO Yujiro S. Hata alla 8th Annual Evercore Healthcare Conference il 3 dicembre 2025 alle ore 10:50 ET.
Una webcast audio in diretta sarà disponibile tramite la pagina Investitori/Eventi di IDEAYA oppure tramite l'organizzatore della conferenza quando consentito, con le repliche delle webcast disponibili per 30 giorni dopo l'evento in diretta.
IDEAYA Biosciences (NASDAQ: IDYA) anunció que la dirección participará en eventos para inversores la semana del 2 de diciembre de 2025.
Las apariciones de la dirección incluyen una charla junto a la chimenea con el CEO Yujiro S. Hata en la Citi Global Healthcare Conference 2025 el 2 de diciembre de 2025 a las 9:00 AM ET y una charla junto a la chimenea con el CEO Yujiro S. Hata en la 8th Annual Evercore Healthcare Conference el 3 de diciembre de 2025 a las 10:50 AM ET.
Una transmisión de audio en vivo estará disponible a través de la página de Inversores/Eventos de IDEAYA o a través del anfitrión de la conferencia cuando esté permitido, con las retransmisiones disponibles durante 30 días después del evento en vivo.
IDEAYA Biosciences (NASDAQ: IDYA) 는 경영진이 2025년 12월 2일 주간에 투자자 행사에 참여할 것이라고 발표했습니다.
경영진의 등장에는 CEO Yujiro S. Hata와의 Fireside 채팅이 Citi Global Healthcare Conference 2025에서 2025년 12월 2일 오전 9시 ET에, 그리고 CEO Yujiro S. Hata와의 Fireside 채팅이 8th Annual Evercore Healthcare Conference에서 2025년 12월 3일 오전 10:50 ET에 열립니다.
라이브 오디오 생중계는 IDEAYA 투자자/이벤트 웹페이지 또는 허용되는 경우 컨퍼런스 주최측을 통해 이용 가능하며, 라이브 이벤트 후 30일간 재생 가능합니다.
IDEAYA Biosciences (NASDAQ: IDYA) a annoncé que la direction participera à des événements pour investisseurs la semaine du 2 décembre 2025.
Les apparitions de la direction incluent une discussion informelle avec le PDG Yujiro S. Hata lors de la Citi Global Healthcare Conference 2025 le 2 décembre 2025 à 9h00 ET et une discussion informelle avec le PDG Yujiro S. Hata lors de la 8e édition de l’Evercore Healthcare Conference le 3 décembre 2025 à 10h50 ET.
Une webdiffusion audio en direct sera disponible via la page Investisseurs/Événements d'IDEAYA ou via l'organisateur de la conférence lorsque cela est autorisé; les rediffusions seront disponibles pendant 30 jours après l'événement en direct.
IDEAYA Biosciences (NASDAQ: IDYA) kündigte an, dass das Management in der Woche vom 2. Dezember 2025 an Investorenveranstaltungen teilnehmen wird.
Zu den Auftritten des Managements gehört ein Fireside-Chat mit dem CEO Yujiro S. Hata bei der Citi Global Healthcare Conference 2025 am 2. Dezember 2025 um 9:00 Uhr ET sowie ein Fireside-Chat mit dem CEO Yujiro S. Hata bei der 8th Annual Evercore Healthcare Conference am 3. Dezember 2025 um 10:50 Uhr ET.
Ein Live-Audio-Webcast wird über die IDEAYA Investors/Events-Webseite oder über den jeweiligen Konferenzveranstalter verfügbar sein, wobei Webcasts nach dem Live-Event für 30 Tage wiedergabefähig sind.
IDEAYA Biosciences (NASDAQ: IDYA) أعلنت الإدارة أنها ستشارك في فعاليات للمستثمرين خلال أسبوع 2 ديسمبر 2025.
تشمل ظهورات الإدارة جلسة دردشة أمام الموقد مع الرئيس التنفيذي يوجيو س. هاتا في Citi Global Healthcare Conference 2025 في 2 ديسمبر 2025 الساعة 9:00 صباحاً بتوقيت شرق الولايات المتحدة وجلسة دردشة أمام الموقد مع الرئيس التنفيذي يوجيو س. هاتا في المؤتمر الصحي Evercore Healthcare Conference 8th Annual في 3 ديسمبر 2025 الساعة 10:50 صباحاً بتوقيت شرق الولايات المتحدة.
سيكون البث الصوتي المباشر متاحاً عبر صفحة IDEAYA Investors/Events أو عبر منظم المؤتمر حيثما سمح بذلك، مع إمكانية إعادة بث التسجيل لمدة 30 يوماً بعد الحدث المباشر.
- None.
- None.
Citi's 2025 Global Healthcare Conference
Tuesday, December 2nd, 2025 at 9:00 AM ET
- Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech Analyst
8th Annual Evercore Healthcare Conference
Wednesday, December 3rd, 2025 at 10:50 AM ET
- Fireside chat with Yujiro S. Hata, President and Chief Executive Officer, hosted by Jonathan Miller, Managing Director, Biotech and Pharma Equity Research
A live audio webcast of the conference events, as permitted by the conference host, will be available at the "Investors/Events" section of the IDEAYA website at https://ir.ideayabio.com/events and/or through the conference host. A replay of available webcasts will be accessible for 30 days following the live event.
About IDEAYA Biosciences
IDEAYA is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in small-molecule drug discovery, structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored, potentially first-in-class targeted therapies aligned to the genetic drivers of disease. We have built a deep pipeline of product candidates focused on synthetic lethality and antibody-drug conjugates, or ADCs, for molecularly defined solid tumor indications. Our mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective, and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's current and future filings with the
Investor and Media Contact
IDEAYA Biosciences
Joshua Bleharski, Ph.D.
Chief Financial Officer
investor@ideayabio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-december-2025-investor-relations-events-302623457.html
SOURCE IDEAYA Biosciences, Inc.
FAQ
When will IDEAYA (IDYA) present at Citi's 2025 Global Healthcare Conference?
What time is IDEAYA (IDYA) scheduled at the Evercore Healthcare Conference on December 3, 2025?
How can investors listen to IDEAYA (IDYA) conference webcasts for December 2025 events?
Will IDEAYA (IDYA) conference webcasts be available after the live events?
Who will host the IDEAYA (IDYA) fireside chats at the December 2025 conferences?
